OSR HEALTH, INC. Operating Cash Flow
OSR HEALTH, INC. (OSRH) reported Operating Cash Flow of -$3.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- OSR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.42M.
- OSR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.00M.
- OSR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.07M.
- OSR HEALTH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.71M.
- OSR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$4.33M.
- OSR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$1.85M.
- OSR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$818.77K.
- OSR HEALTH, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$4.24K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.42M 10-Q · filed 2026-08-14 | -$4.49M derived: sum of 3 quarters · filed 2026-08-14 | -$7.20M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$1.00M 10-Q · filed 2026-05-13 | -$2.07M derived: sum of 2 quarters · filed 2026-05-13 | -$4.78M derived: sum of 3 quarters · filed 2026-05-13 | -$5.27M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$3.78M derived: sum of 2 quarters · filed 2026-03-31 | -$4.26M derived: sum of 3 quarters · filed 2026-08-14 | -$4.33M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.19M derived: sum of 2 quarters · filed 2026-08-14 | -$3.26M 10-Q · filed 2025-11-12 | -$3.44M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$482.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$546.68K 10-Q · filed 2026-08-14 | -$727.71K derived: sum of 3 quarters · filed 2026-08-14 | -$1.41M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$64.07K 10-Q · filed 2026-05-13 | -$64.07K 10-Q · filed 2025-05-20 | -$245.10K derived: sum of 2 quarters · filed 2026-05-13 | -$931.55K derived: sum of 3 quarters · filed 2026-05-13 | -$1.41M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$181.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$867.48K derived: sum of 2 quarters · filed 2026-03-31 | -$1.35M derived: sum of 3 quarters · filed 2026-03-31 | -$1.85M 10-K · filed 2026-03-31 | -$2.19M 10-K · filed 2025-04-22 | |||
| 2024-09-30 | -$686.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.17M derived: sum of 2 quarters · filed 2025-11-12 | -$1.67M 10-Q · filed 2025-11-12 | -$1.69M 10-Q · filed 2024-11-14 | -$1.95M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$483.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$981.99K 10-Q · filed 2025-08-14 | -$1.46M 10-Q · filed 2024-08-19 | -$1.26M derived: sum of 3 quarters · filed 2025-08-14 | -$1.40M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$498.78K 10-Q · filed 2025-05-20 | -$41.78K 10-Q · filed 2024-05-15 | -$778.27K derived: sum of 2 quarters · filed 2025-05-20 | -$921.50K derived: sum of 3 quarters · filed 2025-05-20 | -$1.27M derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | -$279.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-22 | -$422.72K derived: sum of 2 quarters · filed 2025-04-22 | -$770.34K derived: sum of 3 quarters · filed 2025-04-22 | -$818.77K 10-K · filed 2025-04-22 | ||||
| 2023-09-30 | -$143.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$490.85K derived: sum of 2 quarters · filed 2024-11-14 | -$539.27K 10-Q · filed 2024-11-14 | -$540.23K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$347.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$396.05K 10-Q · filed 2024-08-19 | -$397.00K derived: sum of 3 quarters · filed 2024-08-19 | -$393.21K derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | -$48.43K 10-Q · filed 2024-05-15 | -$49.38K derived: sum of 2 quarters · filed 2024-05-15 | -$45.59K derived: sum of 3 quarters · filed 2024-05-15 | -$52.53K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$952.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-17 | $2.84K derived: sum of 2 quarters · filed 2024-04-17 | -$4.11K derived: sum of 3 quarters · filed 2024-04-17 | -$4.24K 10-K · filed 2024-04-17 | ||||
| 2022-09-30 | $3.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.16K derived: sum of 2 quarters · filed 2023-11-07 | -$3.28K 10-Q · filed 2023-11-07 | |||||
| 2022-06-30 | -$6.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$7.07K 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$126.00 10-Q · filed 2023-05-22 | |||||||
| 2021-12-31 | -$461.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |